CMSC Abstracts View

Katie LJ Cederberg, MS, Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

Samantha Stephens, MSc, PhD(c)1, Shahriar Shams, MSc.2, Giulia Longoni, M.D.3, Stephanie A Grover, MSc, CCRP1, Joshua D Lee, PhD4, Tara Berenbaum, BSc5, Marcia Finlayson, PhD, OT Reg (Ont), OTR6, Robert W Motl, PhD7 and E Ann Yeh, MD4, (1)Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, (2)Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, (3)Brain and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, (4)Departments of Neurology and Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, (5)Neurology, The Hospital for Sick Children, Toronto, ON, Canada, (6)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (7)Physical Therapy, University of Alabama, Tuscaloosa, AL

Thomas A Edwards, BKin, Department of Kinesiology and Community Health, University of Illinois at Urbana Champaign, Urbana, IL, Robert W Motl, PhD, Physical Therapy, University of Alabama, Tuscaloosa, AL and Lara A Pilutti, PhD, Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada

Marnina Stimmel, B.A.1,2, Shaina Shagalow, B.A.3, Jeffrey G Portnoy, B.A.3, Roseann Archetti, B.S.3, Elana Mendelowitz, B.A.3, Jessica H Sloan, BA3 and Jason Botvinick, B.A.3, (1)Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

Marnina Stimmel, B.A.1,2, Shaina Shagalow, B.A.3, Jeffrey G Portnoy, B.A.3, Roseann Archetti, B.S.3, Elana Mendelowitz, B.A.3, Jessica H Sloan, BA3 and Jason Botvinick, B.A.3, (1)Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY, (2)MS Center, Holy Name Medical Center, Teaneck, NJ, (3)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY

Andrea Tacchino, PhD1, Mahdis Babazadeh, PT2, Gianluigi Mancardi, MD, PhD3 and Giampaolo Brichetto, MD, PhD1, (1)Scientific Research Area, Italian MS Society, Genoa, Italy, Genova, Italy, (2)Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy, (3)Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy

David E Weinstein, MD, PhD1, Alexey Boyko, MD2, Lisa Pugliese, BA3, Hong Tang, MS3, Barbara Mittleman, MD3, Robert Zivadinov, MD4, Dennis M Lanfear, MBA3 and Barbara Finck, MD3, (1)Coherus Biosciences, Inc., Redwood City, CA, (2)Moscow Multiple Sclerosis Center, Moscow, Russia, (3)Coherus Biosciences, Inc., Redwood City, CA, (4)University at Buffalo, Buffalo, NY

Jennifer A. Ruiz, DPT1, Christopher Gaunya, M.Ac., Dipl.Ac.2, Kayla M. Olson, MA1, Matthew Farr, M.S., P.T.1 and Kathleen Mueller, M.D.2, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT, (2)Center for Integrative Medicine, St. Francis Hospital and Medical Center, Hartford, CT

Scott Belliston, DO, Judy Markwardt-Oberheu, BS and Sharon G Lynch, MD, Neurology, University of Kansas Medical Center, Kansas City, KS

Aaron Boster, MD1, Raed Alroughani, MD2, Regina Berkovich, MD, PhD3, Giancarlo Comi, MD4, Guillermo Izquierdo, MD5, Daniel Kantor, MD6, Christopher LaGanke, MD7, Richard AL Macdonell, MD, FRACP8, Thibault Moreau, MD9, Basil Sharrack, MD, PhD10, Heinz Wiendl, MD11, Bart Van Wijmeersch, MD, PhD12, David H Margolin, MD, PhD13, Karthinathan Thangavelu, PhD13, Maria Melanson, MD, PhD13 and Mark S Freedman, MD14, (1)Ohio State University, Columbus, OH, (2)Amiri Hospital, Sharq, Kuwait, (3)University of Southern California, Keck School of Medicine, Los Angeles, CA, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)Virgen Macarena University Hospital, Seville, Spain, (6)Kantor Neurology, Coconut Creek, FL, (7)North Central Neurology Associates, Cullman, AL, (8)Brain Research Institute, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia, (9)University of Burgundy, Dijon, France, (10)Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom, (11)University of Munster, Munster, Germany, (12)Rehabilitation & MS-Centre Overpelt, Hasselt University, Hasselt, Belgium, (13)Sanofi Genzyme, Cambridge, MA, (14)1University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Aaron E Miller, MD1, Jerome de Seze, MD2, Stephen L Hauser, MD3, Ludwig Kappos, MD4, Jerry Wolinsky, MD5, Jian Han, PhD6, Laura Julian, PhD6, Julie Napieralski, PhD7 and Fred Lublin, MD8, (1)Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, NY, (2)University Hospital of Strasbourg, Strasbourg, France, (3)University of California, San Francisco, San Francisco, CA, (4)University Hospital Basel, University of Basel, Basel, Switzerland, (5)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, (6)Genentech Inc., South San Francisco, CA, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Icahn School of Medicine at Mount Sinai, New York, NY

Aly Jordan, DO, Neurology, Ohio State University, Columbus, OH and Brett Alldredge, DO, Neurology, Ohio State University, Columubs, OH

Maria K Houtchens, MD, Brigham and Women’s Hospital, Brookline, MA, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA and Amy L Phillips, PharmD, EMD Serono, Inc., Rockland, MA

Maria K Houtchens, MD, Brigham and Women’s Hospital, Brookline, MA, Natalie C Edwards, MSc, Health Services Consulting Corporation, Boxborough, MA and Amy L Phillips, PharmD, EMD Serono, Inc., Rockland, MA

Ana Cristina Wing Marques dos Santos, Fellow and Marcelo Kremenchutzky, Director of London MS Clinics, CNS, University of Western Ontario, London, ON, Canada

Anthony T Reder, MD, University of Chicago, Chicago, IL, Gary Cutter, PhD, University of Alabama at Birmingham, Birmingham, AL, Kathleen Hawker, MD, EMD Serono, Inc., Rockland, MA, Julie Aldridge, MS, EMD Serono, Inc., Billerica, MA and Flavia Nelson, MD, University of Texas – McGovern Medical School, Houston, TX

Anthony Traboulsee, MD1, Michael H Barnett, PhD/MD2, Regina Berkovich, MD, PhD3, Aaron Boster, MD4, Giancarlo Comi, MD5, Christopher Laganke, MD6, Daniel Pelletier, MD3, Alex Rovira, MD7, Sven Schippling, MD8, Barry A Singer, MD9, David H Margolin, MD, PhD10, Sourav Santra, PhD11, Douglas L Arnold, MD12,13 and on behalf of the CARE-MS I and CAMMS03409 Investigators, n/a14, (1)University of British Columbia, Vancouver, BC, Canada, (2)Sydney Neuroimaging Analysis Centre, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia, (3)University of Southern California, Keck School of Medicine, Los Angeles, CA, (4)Ohio State University, Columbus, OH, (5)University Vita-Salute San Raffaele, Milan, Italy, (6)North Central Neurology Associates, Cullman, AL, (7)University Hospital Vall d’Hebron, Barcelona, Spain, (8)Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland, (9)MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, (10)Sanofi Genzyme, Cambridge, MA, (11)Cytel, Cambridge, MA, (12)NeuroRx Research, Montreal, QC, Canada, (13)Montreal Neurological Institute and Hospital McGill University, Montreal, QC, Canada, (14)MA

Ashok Vegesna, PharmD1, Huanxue Zhou, MS2, John J Ko, Pharm.D., MS3, Dendy Macaulay, PhD4, Jenny Zhou, PhD4, Luke Schmerold, BS4, Cassie Tang, MS4 and James Signorovitch, PhD4, (1)Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)KMK Consulting, Inc., Florham Park, NJ, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (4)Analysis Group, Inc., New York, NY

Bhupendra Khatri, MD1, Stanley Cohan, MD, PhD2, Sibyl Wray, MD3, Xiaolan Ye, PhD4, Oksana Mokliatchouk, PhD5, Sami Fam, PhD5 and Craig Wakeford, MA5, (1)The Regional MS Center, Center for Neurological Disorders, Wheaton Franciscan Health Care St. Francis Hospital, Milwaukee, WI, (2)Providence Multiple Sclerosis Center, Portland, OR, (3)Hope Neurology MS Center, Knoxville, TN, (4)AbbVie, Mettawa, IL, (5)Biogen, Cambridge, MA

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Barbara E. Teter, PhD, MPH1, S. Ahmed Sanai, MD3, Andrew Goodman, MD1,4, Patricia K Coyle, MD1,5, Lauren Krupp, MD1,6, Malcolm Gottesman, MD1,7 and Keith R Edwards, MD1,8, (1)New York State Multiple Sclerosis Consortium, Buffalo, NY, (2)Jacobs MS Center of Treatment and Research, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)Stony Brook University, Stony Brook, NY, (6)NYU Langone Medical Center, New York, NY, (7)Winthrop Comprehensive MS Care Center, Mineola, NY, (8)MS Center of Northeastern New York, Latham, NY

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Barbara E. Teter, PhD, MPH1, S. Ahmed Sanai, MD3, Andrew Goodman, MD1,4, Patricia K Coyle, MD1,5, Lauren Krupp, MD1,6, Malcolm Gottesman, MD1,7 and Keith R Edwards, MD1,8, (1)New York State Multiple Sclerosis Consortium, Buffalo, NY, (2)Jacobs MS Center of Treatment and Research, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)Stony Brook University, Stony Brook, NY, (6)NYU Langone Medical Center, New York, NY, (7)Winthrop Comprehensive MS Care Center, Mineola, NY, (8)MS Center of Northeastern New York, Latham, NY

Bianca Weinstock-Guttman, MD1,2,3, Caila B Vaughn, PhD, MPH1,2,3, Katelyn S. Kavak, MS1,2,3, Barbara E. Teter, PhD, MPH1, S. Ahmed Sanai, MD3, Andrew Goodman, MD1,4, Patricia K Coyle, MD1,5, Lauren Krupp, MD1,6, Malcolm Gottesman, MD1,7 and Keith R Edwards, MD1,8, (1)New York State Multiple Sclerosis Consortium, Buffalo, NY, (2)Jacobs MS Center of Treatment and Research, Buffalo, NY, (3)Department of Neurology, University at Buffalo, Buffalo, NY, (4)Neurology, University of Rochester, Rochester, NY, (5)Stony Brook University, Stony Brook, NY, (6)NYU Langone Medical Center, New York, NY, (7)Winthrop Comprehensive MS Care Center, Mineola, NY, (8)MS Center of Northeastern New York, Latham, NY

Lisa Laing, BSN, RN, MSCN1, Shannon Haas, MS2, Maayan Elyashiv, BS2, Carrie L Sammarco, DNP, FNP-C, MSCN1 and Cara Desanctis, BSN, RN, MSCN1, (1)MS Comprehensive Care Center, NYU Langone Medical Center, New York, NY, (2)MS Comprehensive Care Center, NYU School of Medicine, New York, NY

Crystal Dixon, MD, Angela Aungst, MPH, Yasir Durrani, MBBS, Lise Casady, ARNP and Derrick Robertson, MD, Neurology, University of South Florida, Tampa, FL

Daniel Jones, PhD1, Mehul Jhaveri, PharmD, MPH2, Ning Wu, PhD2, Kun Yang, PharmD1 and Crystal Watson, MS2, (1)Biogen, Weston, MA, (2)Biogen, Cambridge, MA

David Rog, MD, MRCP1, Nicola Seferta, N/A1, Tatiana Mihalova, MRCP1, Miqun Robinson, MD, PhD2, Susan Colilla, PhD, MPH2, Yang Zhao, PhD2, Tanya Z Fischer, MD, PhD2 and David H Margolin, MD, PhD2, (1)Salford Royal NHS Foundation Trust, Salford, United Kingdom, (2)Sanofi Genzyme, Cambridge, MA

Deborah M Miller, PhD, LISW1, Stephen L Hauser, MD2, Ludwig Kappos, MD3, Fred Lublin, MD4, Xavier Montalban, MD, PhD5, Fiona Mc Dougall, PhD, ClinPsyD6, Gurpreet Deol-Bhullar, BSc, OT7, Jian Han, PhD8, Laura Julian, PhD8, Bruno Musch, MD, PhD8 and Jerry Wolinsky, MD9, (1)Mellen Center, Cleveland Clinic, Cleveland, OH, (2)University of California, San Francisco, San Francisco, CA, (3)University Hospital Basel, University of Basel, Basel, Switzerland, (4)Icahn School of Medicine at Mount Sinai, New York, NY, (5)Multiple Sclerosis Center of Catalonia, Hospital Vall d’Hebron University, Barcelona, Spain, (6)Roche Products Limited, Welwyn Garden City, United Kingdom, (7)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (8)Genentech Inc., South San Francisco, CA, (9)McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX

Edward J Fox, MD1, Florian P Thomas, MD, PhD, MA2, Mark Cascione, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Fernanda Boulos, MD4 and Nadia Tenenbaum, MD4, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Neurology, Hackensack University Medical Center, Hackensack, NJ, (3)Tampa Neurology Associates, Tampa, FL, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Elena Grebenciucova, MD and Eric Williamson, MD, Neurology, University of Pennsylvania, Philadelphia, PA

Felecia Hart, PharmD, MSCS1, Jacquelyn Bainbridge, PharmD, FCCP, MSCS1 and Augusto A Miravalle, M.D.2, (1)University of Colorado, Aurora, CO, (2)Department of Neurology, University of Colorado, Aurora, CO

Florian P Thomas, MD, PhD, MA1, Douglas L Arnold, MD2,3, Mark Cascione, MD4, Edward J Fox, MD5, Maria C Vieria, MD6, John J Ko, Pharm.D., MS6, Xiangyi Meng, PhD6, Lesley Schofield, PhD6, Fernanda Boulos, MD6, Nadia Tenenbaum, MD6 and Bruce AC Cree, MD7, (1)Neurology, Hackensack University Medical Center, Hackensack, NJ, (2)NeuroRx Research, Montreal, QC, Canada, (3)Neurology and Neuroscience, McGill University, Montreal, QC, Canada, (4)Tampa Neurology Associates, Tampa, FL, (5)Central Texas Neurology Consultants, Round Rock, TX, (6)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (7)Multiple Sclerosis Center, San Francisco, CA

Florian P Thomas, MD, PhD, MA1, Bruce AC Cree, MD2, Heidi Crayton, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4, Fernanda Boulos, MD4 and Nadia Tenenbaum, MD4, (1)Neurology, Hackensack University Medical Center, Hackensack, NJ, (2)Multiple Sclerosis Center, San Francisco, CA, (3)MS Center of Greater Washington, Vienna, VA, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Gavin Giovannoni, MD1, Giancarlo Comi, MD2, Stuart Cook, MD3, Peter Rieckmann, MD4, Kottil Rammohan, MD5, Per Soelberg-Sorensen, MD6, Patrick Vermersch, MD7, Christine Hicking, MS8, Abidemi Adeniji, PhD9 and Fernando Dangond, MD9, (1)Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, (2)University Vita-Salute San Raffaele, Milan, Italy, (3)Rutgers, The State University of New Jersey, Newark, NJ, (4)Akademisches Krankenhaus Sozialstiftung Bamberg, Bamberg, Germany, (5)Ohio State University Hospital, Columbus, OH, (6)Copenhagen University Hospital, Copenhagen, Denmark, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)Merck KGaA, Darmstadt, Germany, (9)EMD Serono, Inc., Billerica, MA

Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Xavier Montalban, MD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Christine Hicking, MS, Merck KGaA, Darmstadt, Germany and Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA

Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Giancarlo Comi, MD, University Vita-Salute San Raffaele, Milan, Italy, Xavier Montalban, MD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Christine Hicking, MS, Merck KGaA, Darmstadt, Germany and Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA

Gavin Giovannoni, MD, Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, Xavier Montalban, MD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Christine Hicking, MS, Merck KGaA, Darmstadt, Germany and Fernando Dangond, MD, EMD Serono, Inc., Billerica, MA

Giancarlo Comi, MD1, Thomas Leist, MD2, Mark S Freedman, MD3, Bruce AC Cree, MD4, Patricia K Coyle, MD5, Hans-Peter Hartung, MD6, Patrick Vermersch, MD7, Doris Damian, PhD8 and Fernando Dangond, MD8, (1)University Vita-Salute San Raffaele, Milan, Italy, (2)Thomas Jefferson University, Philadelphia, PA, (3)University of Ottawa and the Ottawa Hospital Research Institute, Ottowa, ON, Canada, (4)Multiple Sclerosis Center, San Francisco, CA, (5)Stony Brook University, Stony Brook, NY, (6)Heinrich Heine University, Dusseldorf, Germany, (7)Univ. Lille, CHU Lille, LIRIC – INSERM U995, Lille, France, (8)EMD Serono, Inc., Billerica, MA

Heather Yong, Undergraduate Student1, Philippe Beauchemin, MD2, Robert Carruthers, MD3, Krista Barclay, RN4, Virginia Devonshire, MD3, Ana-Luiza Sayao, MD3 and Anthony Traboulsee, MD4, (1)Integrated Sciences, University of British Columbia, Vancouver, BC, Canada, (2)UBC MS Clinic, Vancouver, BC, Canada, (3)Neurology, University of British Columbia, Vancouver, BC, Canada, (4)University of British Columbia, Vancouver, BC, Canada

Jeffrey Wilken, PhD1,2, Timothy Fratto, PhD2, Robert L Kane, PhD, ABPP-CN1,2,3, Shannon Kolind, PhD4, Akanksha Mittal, PhD5, Alan K Jacobs, MD5 and Anthony Traboulsee, MD4, (1)Georgetown University, Washington, DC, (2)Washington Neuropsychology Research Group, Washington, DC, (3)University of Maryland School of Medicine, Baltimore, MD, (4)University of British Columbia, Vancouver, BC, Canada, (5)Sanofi Genzyme, Cambridge, MA

Jeffrey Wilken, PhD1,2, Timothy Fratto, PhD2, Robert L Kane, PhD, ABPP-CN1,2,3, Shannon Kolind, PhD4, Akanksha Mittal, PhD5, Alan K Jacobs, MD5 and Anthony Traboulsee, MD4, (1)Georgetown University, Washington, DC, (2)Washington Neuropsychology Research Group, Washington, DC, (3)University of Maryland School of Medicine, Baltimore, MD, (4)University of British Columbia, Vancouver, BC, Canada, (5)Sanofi Genzyme, Cambridge, MA